3.24.1.1.u2 html 369 272 1 false 147 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://oncotelic.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://oncotelic.com/role/BalanceSheets Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://oncotelic.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://oncotelic.com/role/StatementsOfOperations Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statement of Stockholders' Equity (Unaudited) Sheet http://oncotelic.com/role/StatementOfStockholdersEquity Consolidated Statement of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://oncotelic.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION Sheet http://oncotelic.com/role/DescriptionOfBusinessAndBasisOfPresentation DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://oncotelic.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - ACQUISITIONS, GOODWILL AND INTANGIBLE ASSETS Sheet http://oncotelic.com/role/AcquisitionsGoodwillAndIntangibleAssets ACQUISITIONS, GOODWILL AND INTANGIBLE ASSETS Notes 9 false false R10.htm 00000010 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES Sheet http://oncotelic.com/role/AccountsPayableAndAccruedExpenses ACCOUNTS PAYABLE AND ACCRUED EXPENSES Notes 10 false false R11.htm 00000011 - Disclosure - CONVERTIBLE DEBENTURES, NOTES AND OTHER DEBT Notes http://oncotelic.com/role/ConvertibleDebenturesNotesAndOtherDebt CONVERTIBLE DEBENTURES, NOTES AND OTHER DEBT Notes 11 false false R12.htm 00000012 - Disclosure - JOINT VENTURE WITH GMP BIO AND AFFILIATES, EQUITY METHOD INVESTMENT Sheet http://oncotelic.com/role/JointVentureWithGmpBioAndAffiliatesEquityMethodInvestment JOINT VENTURE WITH GMP BIO AND AFFILIATES, EQUITY METHOD INVESTMENT Notes 12 false false R13.htm 00000013 - Disclosure - PRIVATE PLACEMENT (PPM-1) AND JH DARBIE FINANCING Sheet http://oncotelic.com/role/PrivatePlacementPpm-1AndJhDarbieFinancing PRIVATE PLACEMENT (PPM-1) AND JH DARBIE FINANCING Notes 13 false false R14.htm 00000014 - Disclosure - PRIVATE PLACEMENT -2 (PPM-2) AND JH DARBIE FUNDING Sheet http://oncotelic.com/role/PrivatePlacement-2Ppm-2AndJhDarbieFunding PRIVATE PLACEMENT -2 (PPM-2) AND JH DARBIE FUNDING Notes 14 false false R15.htm 00000015 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://oncotelic.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 15 false false R16.htm 00000016 - Disclosure - EQUITY PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT Sheet http://oncotelic.com/role/EquityPurchaseAgreementAndRegistrationRightsAgreement EQUITY PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT Notes 16 false false R17.htm 00000017 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://oncotelic.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 17 false false R18.htm 00000018 - Disclosure - STOCK-BASED COMPENSATION Sheet http://oncotelic.com/role/Stock-basedCompensation STOCK-BASED COMPENSATION Notes 18 false false R19.htm 00000019 - Disclosure - INCOME TAXES Sheet http://oncotelic.com/role/IncomeTaxes INCOME TAXES Notes 19 false false R20.htm 00000020 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://oncotelic.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 20 false false R21.htm 00000021 - Disclosure - SUBSEQUENT EVENTS Sheet http://oncotelic.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 21 false false R22.htm 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://oncotelic.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 22 false false R23.htm 00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://oncotelic.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://oncotelic.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 00000024 - Disclosure - ACQUISITIONS, GOODWILL AND INTANGIBLE ASSETS (Tables) Sheet http://oncotelic.com/role/AcquisitionsGoodwillAndIntangibleAssetsTables ACQUISITIONS, GOODWILL AND INTANGIBLE ASSETS (Tables) Tables http://oncotelic.com/role/AcquisitionsGoodwillAndIntangibleAssets 24 false false R25.htm 00000025 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) Sheet http://oncotelic.com/role/AccountsPayableAndAccruedExpensesTables ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) Tables http://oncotelic.com/role/AccountsPayableAndAccruedExpenses 25 false false R26.htm 00000026 - Disclosure - CONVERTIBLE DEBENTURES, NOTES AND OTHER DEBT (Tables) Notes http://oncotelic.com/role/ConvertibleDebenturesNotesAndOtherDebtTables CONVERTIBLE DEBENTURES, NOTES AND OTHER DEBT (Tables) Tables http://oncotelic.com/role/ConvertibleDebenturesNotesAndOtherDebt 26 false false R27.htm 00000027 - Disclosure - JOINT VENTURE WITH GMP BIO AND AFFILIATES, EQUITY METHOD INVESTMENT (Tables) Sheet http://oncotelic.com/role/JointVentureWithGmpBioAndAffiliatesEquityMethodInvestmentTables JOINT VENTURE WITH GMP BIO AND AFFILIATES, EQUITY METHOD INVESTMENT (Tables) Tables http://oncotelic.com/role/JointVentureWithGmpBioAndAffiliatesEquityMethodInvestment 27 false false R28.htm 00000028 - Disclosure - PRIVATE PLACEMENT (PPM-1) AND JH DARBIE FINANCING (Tables) Sheet http://oncotelic.com/role/PrivatePlacementPpm-1AndJhDarbieFinancingTables PRIVATE PLACEMENT (PPM-1) AND JH DARBIE FINANCING (Tables) Tables http://oncotelic.com/role/PrivatePlacementPpm-1AndJhDarbieFinancing 28 false false R29.htm 00000029 - Disclosure - PRIVATE PLACEMENT -2 (PPM-2) AND JH DARBIE FUNDING (Tables) Sheet http://oncotelic.com/role/PrivatePlacement-2Ppm-2AndJhDarbieFundingTables PRIVATE PLACEMENT -2 (PPM-2) AND JH DARBIE FUNDING (Tables) Tables http://oncotelic.com/role/PrivatePlacementPpm-1AndJhDarbieFinancing 29 false false R30.htm 00000030 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://oncotelic.com/role/Stock-basedCompensationTables STOCK-BASED COMPENSATION (Tables) Tables http://oncotelic.com/role/Stock-basedCompensation 30 false false R31.htm 00000031 - Disclosure - SCHEDULE OF UNREALIZED GAINS AND LOSSES (Details) Sheet http://oncotelic.com/role/ScheduleOfUnrealizedGainsAndLossesDetails SCHEDULE OF UNREALIZED GAINS AND LOSSES (Details) Details 31 false false R32.htm 00000032 - Disclosure - SUMMARY OF CHANGES IN FAIR VALUE OF DERIVATIVE LIABILITIES (Details) Sheet http://oncotelic.com/role/SummaryOfChangesInFairValueOfDerivativeLiabilitiesDetails SUMMARY OF CHANGES IN FAIR VALUE OF DERIVATIVE LIABILITIES (Details) Details 32 false false R33.htm 00000033 - Disclosure - SUMMARY OF ESTIMATE FAIR VALUE OF DERIVATIVE LIABILITIES (Details) Sheet http://oncotelic.com/role/SummaryOfEstimateFairValueOfDerivativeLiabilitiesDetails SUMMARY OF ESTIMATE FAIR VALUE OF DERIVATIVE LIABILITIES (Details) Details 33 false false R34.htm 00000034 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) Sheet http://oncotelic.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) Details http://oncotelic.com/role/DescriptionOfBusinessAndBasisOfPresentation 34 false false R35.htm 00000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://oncotelic.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://oncotelic.com/role/SummaryOfSignificantAccountingPoliciesTables 35 false false R36.htm 00000036 - Disclosure - SUMMARY OF GOODWILL (Details) Sheet http://oncotelic.com/role/SummaryOfGoodwillDetails SUMMARY OF GOODWILL (Details) Details 36 false false R37.htm 00000037 - Disclosure - ACQUISITIONS, GOODWILL AND INTANGIBLE ASSETS (Details Narrative) Sheet http://oncotelic.com/role/AcquisitionsGoodwillAndIntangibleAssetsDetailsNarrative ACQUISITIONS, GOODWILL AND INTANGIBLE ASSETS (Details Narrative) Details http://oncotelic.com/role/AcquisitionsGoodwillAndIntangibleAssetsTables 37 false false R38.htm 00000038 - Disclosure - SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) Sheet http://oncotelic.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) Details 38 false false R39.htm 00000039 - Disclosure - SCHEDULE OF CONVERTIBLE DEBENTURES AND NOTES, NET OF DISCOUNT (Details) Notes http://oncotelic.com/role/ScheduleOfConvertibleDebenturesAndNotesNetOfDiscountDetails SCHEDULE OF CONVERTIBLE DEBENTURES AND NOTES, NET OF DISCOUNT (Details) Details 39 false false R40.htm 00000040 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES, NET OF DISCOUNT (Details) Notes http://oncotelic.com/role/ScheduleOfConvertibleNotesNetOfDiscountDetails SCHEDULE OF CONVERTIBLE NOTES, NET OF DISCOUNT (Details) Details 40 false false R41.htm 00000041 - Disclosure - SCHEDULE OF SHORT-TERM LOANS (Details) Sheet http://oncotelic.com/role/ScheduleOfShort-termLoansDetails SCHEDULE OF SHORT-TERM LOANS (Details) Details 41 false false R42.htm 00000042 - Disclosure - CONVERTIBLE DEBENTURES, NOTES AND OTHER DEBT (Details Narrative) Notes http://oncotelic.com/role/ConvertibleDebenturesNotesAndOtherDebtDetailsNarrative CONVERTIBLE DEBENTURES, NOTES AND OTHER DEBT (Details Narrative) Details http://oncotelic.com/role/ConvertibleDebenturesNotesAndOtherDebtTables 42 false false R43.htm 00000043 - Disclosure - SCHEDULE OF CHANGE IN FAIR VALUE OF OUR INVESTMENT (Details) Sheet http://oncotelic.com/role/ScheduleOfChangeInFairValueOfOurInvestmentDetails SCHEDULE OF CHANGE IN FAIR VALUE OF OUR INVESTMENT (Details) Details 43 false false R44.htm 00000044 - Disclosure - JOINT VENTURE WITH GMP BIO AND AFFILIATES, EQUITY METHOD INVESTMENT (Details Narrative) Sheet http://oncotelic.com/role/JointVentureWithGmpBioAndAffiliatesEquityMethodInvestmentDetailsNarrative JOINT VENTURE WITH GMP BIO AND AFFILIATES, EQUITY METHOD INVESTMENT (Details Narrative) Details http://oncotelic.com/role/JointVentureWithGmpBioAndAffiliatesEquityMethodInvestmentTables 44 false false R45.htm 00000045 - Disclosure - SCHEDULE OF FUNDS RECEIVED UNDER THE SUBSCRIPTION AGREEMENT (Details) Sheet http://oncotelic.com/role/ScheduleOfFundsReceivedUnderSubscriptionAgreementDetails SCHEDULE OF FUNDS RECEIVED UNDER THE SUBSCRIPTION AGREEMENT (Details) Details 45 false false R46.htm 00000046 - Disclosure - PRIVATE PLACEMENT (PPM-1) AND JH DARBIE FINANCING (Details Narrative) Sheet http://oncotelic.com/role/PrivatePlacementPpm-1AndJhDarbieFinancingDetailsNarrative PRIVATE PLACEMENT (PPM-1) AND JH DARBIE FINANCING (Details Narrative) Details http://oncotelic.com/role/PrivatePlacementPpm-1AndJhDarbieFinancingTables 46 false false R47.htm 00000047 - Disclosure - SCHEDULE OF FAIR VALUE WARRANTS (Details) Sheet http://oncotelic.com/role/ScheduleOfFairValueWarrantsDetails SCHEDULE OF FAIR VALUE WARRANTS (Details) Details 47 false false R48.htm 00000048 - Disclosure - PRIVATE PLACEMENT -2 (PPM-2) AND JH DARBIE FUNDING (Details Narrative) Sheet http://oncotelic.com/role/PrivatePlacement-2Ppm-2AndJhDarbieFundingDetailsNarrative PRIVATE PLACEMENT -2 (PPM-2) AND JH DARBIE FUNDING (Details Narrative) Details http://oncotelic.com/role/PrivatePlacementPpm-1AndJhDarbieFinancingTables 48 false false R49.htm 00000049 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://oncotelic.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://oncotelic.com/role/RelatedPartyTransactions 49 false false R50.htm 00000050 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://oncotelic.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://oncotelic.com/role/StockholdersEquity 50 false false R51.htm 00000051 - Disclosure - SCHEDULE OF COMPENSATION BASED STOCK OPTION ACTIVITY (Details) Sheet http://oncotelic.com/role/ScheduleOfCompensationBasedStockOptionActivityDetails SCHEDULE OF COMPENSATION BASED STOCK OPTION ACTIVITY (Details) Details 51 false false R52.htm 00000052 - Disclosure - SCHEDULE OF OPTIONS TO PURCHASE SHARES OF COMMON STOCK OUTSTANDING AND EXERCISABLE (Details) Sheet http://oncotelic.com/role/ScheduleOfOptionsToPurchaseSharesOfCommonStockOutstandingAndExercisableDetails SCHEDULE OF OPTIONS TO PURCHASE SHARES OF COMMON STOCK OUTSTANDING AND EXERCISABLE (Details) Details 52 false false R53.htm 00000053 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details) Sheet http://oncotelic.com/role/ScheduleOfWarrantsActivityDetails SCHEDULE OF WARRANTS ACTIVITY (Details) Details 53 false false R54.htm 00000054 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details) Sheet http://oncotelic.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details) Details 54 false false R55.htm 00000055 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative) Sheet http://oncotelic.com/role/Stock-basedCompensationDetailsNarrative STOCK-BASED COMPENSATION (Details Narrative) Details http://oncotelic.com/role/Stock-basedCompensationTables 55 false false R56.htm 00000056 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://oncotelic.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://oncotelic.com/role/IncomeTaxes 56 false false R57.htm 00000057 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://oncotelic.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://oncotelic.com/role/CommitmentsAndContingencies 57 false false R58.htm 00000058 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://oncotelic.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://oncotelic.com/role/SubsequentEvents 58 false false All Reports Book All Reports [EXG.rendering.tooManyDimensions] Presentation group http://oncotelic.com/role/ConvertibleDebenturesNotesAndOtherDebtDetailsNarrative with 11 axes could have more than 17 billion cells. Split up this presentation group and see EXG, Rendering, to see how to reduce the number of combinations by selecting fewer members for each axis. - form10-q.htm - form10-q.htm form10-q.htm otlc-20240331.xsd otlc-20240331_cal.xml otlc-20240331_def.xml otlc-20240331_lab.xml otlc-20240331_pre.xml http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 true true